See every side of every news story

Published 16 days ago • loading... • Updated 16 days ago

BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026

Summary by Benzinga

BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature data from clinical asset BV100 addressing carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) hospital infections and preclinical asset BV500 addressing non-tuberculosis mycobacteria (NTM) infections. Experts from the UK, Greece and Switzerland to share preclinical insights on BV100's activity against CRABC on Sunday, April 19, 2026. Bi…

3 Articles

3 Articles

+2 Reposted by 2 other sources

BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026

BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature data from clinical asset BV100 addressing carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) hospital infections and preclinical asset BV500 addressing non-tuberculosis mycobacteria (NTM) infections. Experts from the UK, Greece and Switzerland to share preclinical insights on BV100's activity against CRABC on Sunday, April 19, 2026. Bi…

16 days ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left0Leaning Right1Center1Last Updated16 days agoBias Distribution

50% Center, 50% Right

Bias Distribution

50% of the sources are Center, 50% of the sources lean Right

50% Right

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States 16 days ago on Wednesday, April 15, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics